Daniel Baumhoer
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool
Amary F, Baumhoer D, O'Donnell P, Pillay N, Lindsay D, Tirabosco R, Cool P, Gerrand C, Ye H, Berisha F, Markert E, Flanagan A. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool. Am J Surg Pathol 2019; 43:1661-1667.
Dec 1, 2019FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool
Dec 1, 2019Am J Surg Pathol 2019; 43:1661-1667
Amary Fernanda, Baumhoer Daniel, O'Donnell Paul, Pillay Nischalan, Lindsay Daniel, Tirabosco Roberto, Cool Paul, Gerrand Craig, Ye Hongtao, Berisha Fitim, Markert Eva, Flanagan Adrienne M
Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
Kollár A, Rothermundt C, Klenke F, Bode B, Baumhoer D, Arndt V, Feller A, NICER Working Group. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiol 2019; 63:101596.
Sep 11, 2019Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
Sep 11, 2019Cancer Epidemiol 2019; 63:101596
Kollár Attila, Rothermundt Christian, Klenke Frank, Bode Beata, Baumhoer Daniel, Arndt Volker, Feller Anita, NICER Working Group
Systematic identification of cancer-specific MHC-binding peptides with RAVEN
Baldauf M, Hasegawa T, Sugimura H, Baumhoer D, Knott M, Sannino G, Marchetto A, Li J, Busch D, Feuchtinger T, Ohmura S, Orth M, Thiel U, Kirchner T, Sugita S, Özen Ö, Gerke J, Kirschner A, Blaeschke F, Effenberger M, Schober K, Rubio R, Kanaseki T, Kiran M, Dallmayer M, Musa J, Akpolat N, Akatli A, Rosman F, Grünewald T. Systematic identification of cancer-specific MHC-binding peptides with RAVEN. Oncoimmunology 2018; 7:e1481558.
Jul 23, 2018Systematic identification of cancer-specific MHC-binding peptides with RAVEN
Jul 23, 2018Oncoimmunology 2018; 7:e1481558
Baldauf Michaela, Hasegawa Tadashi, Sugimura Haruhiko, Baumhoer Daniel, Knott Maximilian M L, Sannino Giuseppina, Marchetto Aruna, Li Jing, Busch Dirk H, Feuchtinger Tobias, Ohmura Shunya, Orth Martin F, Thiel Uwe, Kirchner Thomas, Sugita Shintaro, Özen Özlem, Gerke Julia S, Kirschner Andreas, Blaeschke Franziska, Effenberger Manuel, Schober Kilian, Rubio Rebeca Alba, Kanaseki Takayuki, Kiran Merve M, Dallmayer Marlene, Musa Julian, Akpolat Nurset, Akatli Ayse N, Rosman Fernando C, Grünewald Thomas G P
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Baldauf M, Gerke J, Orth M, Dallmayer M, Baumhoer D, de Alava E, Hartmann W, Kirchner T, Grünewald T. Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?. Mod Pathol 2018; 31:997-999.
Jun 12, 2018Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Jun 12, 2018Mod Pathol 2018; 31:997-999
Baldauf Michaela, Gerke Julia S, Orth Martin F, Dallmayer Marlene, Baumhoer Daniel, de Alava Enrique, Hartmann Wolfgang, Kirchner Thomas, Grünewald Thomas G P
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets
Baldauf M, Akatli A, Özen Ö, Dirksen U, Hartmann W, de Alava E, Baumhoer D, Sannino G, Kirchner T, Akpolat N, Li J, Ohmura S, Orth M, Dallmayer M, Marchetto A, Gerke J, Rubio R, Kiran M, Musa J, Knott M, Grünewald T. Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Oncotarget 2017; 9:1587-1601.
Aug 4, 2017Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets
Aug 4, 2017Oncotarget 2017; 9:1587-1601
Baldauf Michaela, Akatli Ayse N, Özen Özlem, Dirksen Uta, Hartmann Wolfgang, de Alava Enrique, Baumhoer Daniel, Sannino Giuseppina, Kirchner Thomas, Akpolat Nusret, Li Jing, Ohmura Shunya, Orth Martin F, Dallmayer Marlene, Marchetto Aruna, Gerke Julia S, Rubio Rebeca Alba, Kiran Merve M, Musa Julian, Knott Maximilian M L, Grünewald Thomas G P